University of Dundee-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Dundee - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013175
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Dundee (Dundee) is an educational research university that offers a range of undergraduate, postgraduate, postgraduate research degree, distant learning and English language programs. The university offers a wide range of academic and research courses in various disciplines such as accounting, arts, philosophy, law, language, engineering, economics, medicine, healthcare, finance and biochemistry, among others. It also offers a range of services and consultancy support such as advice and opinion, design and evaluation of commercial drug trials, prototype design and development, laboratory based testing and analysis, proof-of-principle testing of new and emerging technologies, assessment of existing processes, customized training, strategic planning, representation on scientific advisory boards, and others. The university operates through its City campus, Ninewells campus and Kirkcaldy campus. Dundee is headquartered in Dundee, the UK.

University of Dundee – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Dundee, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Dundee, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Dundee, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Dundee, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Dundee, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
University of Dundee, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Drug Discovery Unit Enters into Agreement with Corbin Therapeutics 10
Boehringer Ingelheim and University of Dundee Enter into Agreement 11
Wave Life Sciences Enters into Research Agreement with University of Dundee 12
University of Dundee Enters into Research Agreement with Pfizer 13
University of Dundee Enters into Co-Development Agreement with Ubiquigent 14
GlaxoSmithKline Enters Into Co-Development Agreement With University of Dundee 15
GlaxoSmithKline Enters Into Co-Development Agreement With University of Dundee For Huntington’s Disease 16
GlaxoSmithKline Enters Into Co-Development Agreement With University of Dundee 17
Licensing Agreements 18
University Of Dundee Enters Into Licensing Agreement With GVK Biosciences For Gostar 18
University of Dundee – Key Competitors 19
University of Dundee – Key Employees 20
University of Dundee – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Government and Public Interest 22
Sep 17, 2017: £2million award for cancer researcher 22
Mar 13, 2017: University of Dundee: A kiss of death to drug the ‘undruggable’ 23
Product News 25
Jul 17, 2017: New Test Paves Way for Potential Treatments to Target Alzheimer’s and Other Conditions 25
May 11, 2016: New UK-wide clinical trial aims to improve muscle strength in older people 26
Apr 19, 2016: New trial aims to prevent type 1 diabetes 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
University of Dundee, Pharmaceuticals & Healthcare, Key Facts 2
University of Dundee, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Dundee, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Dundee, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Dundee, Deals By Therapy Area, 2011 to YTD 2017 8
University of Dundee, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Drug Discovery Unit Enters into Agreement with Corbin Therapeutics 10
Boehringer Ingelheim and University of Dundee Enter into Agreement 11
Wave Life Sciences Enters into Research Agreement with University of Dundee 12
University of Dundee Enters into Research Agreement with Pfizer 13
University of Dundee Enters into Co-Development Agreement with Ubiquigent 14
GlaxoSmithKline Enters Into Co-Development Agreement With University of Dundee 15
GlaxoSmithKline Enters Into Co-Development Agreement With University of Dundee For Huntington's Disease 16
GlaxoSmithKline Enters Into Co-Development Agreement With University of Dundee 17
University Of Dundee Enters Into Licensing Agreement With GVK Biosciences For Gostar 18
University of Dundee, Key Competitors 19
University of Dundee, Key Employees 20
University of Dundee, Subsidiaries 21

★海外企業調査レポート[University of Dundee-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Creganna Medical:医療機器:M&Aディール及び事業提携情報
    Summary Creganna Medical (Creganna), a subsidiary of TE Connectivity Ltd, formerly known as Creganna-Tactx Medical, is a provider of medical device outsourcing solutions. The company is. It undertakes the design, manufacturing and commercialization of minimally & less invasive delivery and access de …
  • F-Secure Oyj (FSC1V):企業の財務・戦略的SWOT分析
    F-Secure Oyj (FSC1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cosmo Bio Co Ltd (3386):企業の財務・戦略的SWOT分析
    Summary Cosmo Bio Co Ltd (Cosmo Bio) operates as a medical device company that offers markets research reagents and research instruments. The company’s product categories include antibodies, assay and detection, cells and cell culture, bioactive substances, protein engineering, separation and purifi …
  • Chatham Lodging Trust:企業のM&A・事業提携・投資動向
    Chatham Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chatham Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Tatung Co. Ltd. (2371):企業の財務・戦略的SWOT分析
    Summary Tatung Co. Ltd. (Tatung) is an electronic product manufacturer that designs, manufactures, distributes and sells digital consumer products. The company operates through its business group such as power, consumer and system solution group. Its power business group provides transformers, switc …
  • RayBiotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary RayBiotech Inc (RayBiotech) is a life science company that provides proteins, antibodies and immunological kits. The company's product categories include antibody arrays, glycobiology arrays, protein arrays, phosphorylation arrays, elisa, functional assays, antibodies and custom recombinant …
  • GMR Infrastructure Ltd (GMRINFRA):電力:M&Aディール及び事業提携情報
    Summary GMR Infrastructure Limited (GMR), a subsidiary of GMR Group, is a construction company. The company executes various projects across airport, energy, transportation and urban infrastructure sectors. The company owns and operates Delhi's Indira Gandhi International Airport, Rajiv Gandhi Inter …
  • International Finance Corporation:企業の戦略的SWOT分析
    International Finance Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Nippon Sheet Glass Company Limited :企業の戦略・SWOT・財務情報
    Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Astex Pharmaceuticals Inc:企業の戦略的SWOT分析
    Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sime Darby Bhd (SIME):電力:M&Aディール及び事業提携情報
    Summary Sime Darby Bhd (Sime Darby) is a trading and logistics company. It provides diversified products and services through its subsidiaries, affiliates, and joint ventures. The company cultivates oil palm, rubber and sugarcane; rears cattle; and produces oil and fats. It also imports, assembles, …
  • Mediware Information Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mediware Information Systems Inc (Mediware) is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solutions are equipped in blood banks …
  • Censo Biotechnologies Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Censo Biotechnologies Ltd (Censo) formerly Roslin Cellab Limited, a subsidiary of Roslin Foundation, is a provider of human cells and contract research services for drug discovery, toxicity testing and cell banking. The company offers iPSC services; differentiated cell types; in vitro assays …
  • Federal Grid Company of Unified Energy System (FEES):電力:M&Aディール及び事業提携情報
    Summary Federal Grid Company of Unified Energy System (FGC UES), a subsidiary of Rosseti, is an energy company. It operates and manages unified national electricity transmission grid system. The company transmits electricity to distribution grid companies, large commercial end customers and retail e …
  • HCL Technologies Ltd (HCLTECH):企業の財務・戦略的SWOT分析
    HCL Technologies Ltd (HCLTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Fulgent Genetics Inc (FLGT):企業の財務・戦略的SWOT分析
    Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Emirates Retakaful Limited:企業の戦略・SWOT・財務情報
    Emirates Retakaful Limited - Strategy, SWOT and Corporate Finance Report Summary Emirates Retakaful Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Regal Hotels International Holdings Ltd:企業の戦略・SWOT・財務情報
    Regal Hotels International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Regal Hotels International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Melkior Resources Inc. (MKR):企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Information Services International-Dentsu Ltd (4812):企業の財務・戦略的SWOT分析
    Information Services International-Dentsu Ltd (4812) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆